Roche, Genentech Acquire Unlimited Access to Open Monoclonal Technology's OmniRat®
December 18, 2013 at 09:08 AM EST
Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche Group, and Roche (OTC: RHHBY ) will acquire